Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Human Pathology|May 4, 2018
Frozen section evaluation via dynamic real-time nonrobotic telepathology system in a university cancer center by resident/faculty cooperation teamAram Vosoughi, Paul Taylor Smith, Joseph A Zeitouni, et al.Molecular Cancer Research : MCR|October 19, 2018
Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the ProstateHabiba Elfandy, Joshua Armenia, Filippo Pederzoli, et al.Current Oncology Reports|June 5, 2024
From Detection to Cure - Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder CancerJoshua A Linscott, Hiroko Miyagi, Prithvi B Murthy, et al.The Journal of Infectious Diseases|August 1, 2013
A targeted and adjuvanted nanocarrier lowers the effective dose of liposomal amphotericin B and enhances adaptive immunity in murine cutaneous leishmaniasisPirouz M Daftarian, Geoffrey W Stone, Leticia Kovalski, et al.Nature Reviews. Urology|March 28, 2023
Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic diseaseKyle M Rose, Heather L Huelster, Joshua J Meeks, et al.Urologic Oncology|March 23, 2023
Impact of surgical margin and extent of lymphadenectomy on oncologic outcomes in plasmacytoid urothelial carcinomaFacundo Davaro, Elizabeth Davaro, Kyle Rose, et al.Urologic Oncology|October 25, 2023
Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancerRoger Li, Shreyas Naidu, Wenyi Fan, et al.Nature Communications|March 19, 2024
The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysisKentaro Ohara, André Figueiredo Rendeiro, Bhavneet Bhinder, et al.European Urology|October 6, 2023
Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial CarcinomaHeather L Huelster, Billie Gould, Elizabeth A Schiftan, et al.Science Translational Medicine|March 22, 2019
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancerLoredana Puca, Katie Gavyert, Verena Sailer, et al.Pageof 3